Pharmaceutical companies update market, pitch products, at conference

Hanmi Pharmaceutical is expected to receive U.S. Food and Drug Administration (FDA) marketing approvals for two new drugs this year, CEO Kwon Se-chang said during the 40th annual J.P. Morgan HealthCare Conference.